ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Phreesia’s Zeeshan Butt Named to NQF’s MAP Clinician Workgroup

Phreesia is proud to announce that Zeeshan Butt, PhD, a Director of Clinical Content, has been selected to serve a three-year term as a member of the National Quality Forum (NQF)’s Measure Applications Partnership (MAP) 2022-2023 Clinician Workgroup.

NQF convened MAP in 2011, in partnership with the Centers for Medicare & Medicaid Services (CMS), to provide input to the U.S. Department of Health and Human Services (HHS) on the selection of performance measures for public reporting and performance-based payment programs. MAP is a diverse, multi-stakeholder group that includes leaders and experts from health plans, suppliers, provider organizations, community health agencies and other entities.

The Clinician Workgroup will provide recommendations on issues related to the selection and coordination of measures that would impact clinicians, particularly in the office setting, such as those in the Merit-Based Incentive Payment System (MIPS).

Dr. Butt is a licensed clinical health psychologist and Phreesia’s resident expert in patient-reported outcomes (PROs) and clinical quality measurement. At Phreesia, he works closely with health systems and provider groups to help them implement screening tools and PROs, improve health outcomes and meet quality goals.

“As a health psychologist, I am honored to have been invited to join as a subject matter expert and member of this workgroup,” said Dr. Butt. “I believe our work will help to amplify the voice of clinicians toward the selection of performance measures for federal public reporting, performance-based payment and other health programs.”

Phreesia facilitates more than 100 million visits a year. Its intake platform offers healthcare providers the ability to collect key patient-reported data, and Phreesia is also the steward of the Patient Activation Measure® (PAM®), a survey that assesses patients’ underlying knowledge, skills and confidence to manage their own health. PAM is backed by research demonstrating that higher scores are associated with better clinical outcomes, higher patient satisfaction with care and lower healthcare costs. PAM has also been successfully used as a performance metric, PAM-PM, which has been endorsed by the NQF.

About Phreesia

Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform activates patients in their healthcare and provides a modern, convenient experience, while enabling our clients to enhance clinical care and drive efficiency.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.53
+0.42 (0.18%)
AAPL  278.78
-1.92 (-0.68%)
AMD  217.97
+1.99 (0.92%)
BAC  53.95
+0.07 (0.13%)
GOOG  322.09
+3.70 (1.16%)
META  673.42
+11.89 (1.80%)
MSFT  483.16
+2.32 (0.48%)
NVDA  182.41
-0.97 (-0.53%)
ORCL  217.58
+3.25 (1.52%)
TSLA  455.00
+0.47 (0.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.